Hemolysis during cardiac extracorporeal membrane oxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatric population

Jonathan Byrnes, Wes McKamie, Christopher Swearingen, Parthak Prodhan, Adnan Bhutta, Robert Jaquiss, Michiaki Imamura, Richard Fiser

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) is a lifesaving therapy, which has been used for the support of children with a broad range of diseases. Two pumps of differing mechanisms have been used to generate the extracorporeal flow: roller-head pumps and centrifugal pumps. Seven patients supported during ECMO with Levitronix Centrimag (Centrimag group [CG]) were matched to 14 patients supported with Stockert-Shiley SIII (Stockert-Shiley group [SSG]) at a single institution from July 2007 to July 2009. We hypothesized that hemolysis as measured by plasma-free hemoglobin (PFH) is elevated in the SSG versus the CG during cardiac ECMO. Categorical data were analyzed using Fisher's exact test. Plasma-free hemoglobin differences between groups were analyzed using both Wilcoxon rank sum and beta regression. Overall, SSG patients had two times the odds of having a higher PFH than CG patients adjusting for repeated measures (odds ratio [OR] = 1.96, 95% confidence interval [CI]: [1.15-3.34], p < 0.014). Differences between circuit failure in the first 168 hours did not reach statistical significance (1/7 CG vs. 7/14 SSG; p = 0.174). In this population of cardiac patients requiring ECMO support, more hemolysis occurred in the SSG, a roller-head pump supported group, when compared with the CG, a centrifugal pump supported group. Differences in circuit life did not reach statistical significance. This pilot study contrasts with past studies, which have demonstrated more hemolysis occurring with centrifugal pumps when compared with roller-head pumps.

Original languageEnglish (US)
Pages (from-to)456-461
Number of pages6
JournalASAIO Journal
Volume57
Issue number5
DOIs
StatePublished - Sep 1 2011

Fingerprint

Extracorporeal Membrane Oxygenation
Pediatrics
Oxygenation
Centrifugal pumps
Hemolysis
Hemoglobin
Pumps
Membranes
Hemoglobins
Plasmas
Population
Head
Networks (circuits)
Research Design
Odds Ratio
Confidence Intervals

ASJC Scopus subject areas

  • Biophysics
  • Biomaterials
  • Bioengineering
  • Biomedical Engineering
  • Medicine(all)

Cite this

Hemolysis during cardiac extracorporeal membrane oxygenation : A case-control comparison of roller pumps and centrifugal pumps in a pediatric population. / Byrnes, Jonathan; McKamie, Wes; Swearingen, Christopher; Prodhan, Parthak; Bhutta, Adnan; Jaquiss, Robert; Imamura, Michiaki; Fiser, Richard.

In: ASAIO Journal, Vol. 57, No. 5, 01.09.2011, p. 456-461.

Research output: Contribution to journalArticle

Byrnes, Jonathan ; McKamie, Wes ; Swearingen, Christopher ; Prodhan, Parthak ; Bhutta, Adnan ; Jaquiss, Robert ; Imamura, Michiaki ; Fiser, Richard. / Hemolysis during cardiac extracorporeal membrane oxygenation : A case-control comparison of roller pumps and centrifugal pumps in a pediatric population. In: ASAIO Journal. 2011 ; Vol. 57, No. 5. pp. 456-461.
@article{3226e25ca98141f1be0924a6bf10701d,
title = "Hemolysis during cardiac extracorporeal membrane oxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatric population",
abstract = "Extracorporeal membrane oxygenation (ECMO) is a lifesaving therapy, which has been used for the support of children with a broad range of diseases. Two pumps of differing mechanisms have been used to generate the extracorporeal flow: roller-head pumps and centrifugal pumps. Seven patients supported during ECMO with Levitronix Centrimag (Centrimag group [CG]) were matched to 14 patients supported with Stockert-Shiley SIII (Stockert-Shiley group [SSG]) at a single institution from July 2007 to July 2009. We hypothesized that hemolysis as measured by plasma-free hemoglobin (PFH) is elevated in the SSG versus the CG during cardiac ECMO. Categorical data were analyzed using Fisher's exact test. Plasma-free hemoglobin differences between groups were analyzed using both Wilcoxon rank sum and beta regression. Overall, SSG patients had two times the odds of having a higher PFH than CG patients adjusting for repeated measures (odds ratio [OR] = 1.96, 95{\%} confidence interval [CI]: [1.15-3.34], p < 0.014). Differences between circuit failure in the first 168 hours did not reach statistical significance (1/7 CG vs. 7/14 SSG; p = 0.174). In this population of cardiac patients requiring ECMO support, more hemolysis occurred in the SSG, a roller-head pump supported group, when compared with the CG, a centrifugal pump supported group. Differences in circuit life did not reach statistical significance. This pilot study contrasts with past studies, which have demonstrated more hemolysis occurring with centrifugal pumps when compared with roller-head pumps.",
author = "Jonathan Byrnes and Wes McKamie and Christopher Swearingen and Parthak Prodhan and Adnan Bhutta and Robert Jaquiss and Michiaki Imamura and Richard Fiser",
year = "2011",
month = "9",
day = "1",
doi = "10.1097/MAT.0b013e31822e2475",
language = "English (US)",
volume = "57",
pages = "456--461",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Hemolysis during cardiac extracorporeal membrane oxygenation

T2 - A case-control comparison of roller pumps and centrifugal pumps in a pediatric population

AU - Byrnes, Jonathan

AU - McKamie, Wes

AU - Swearingen, Christopher

AU - Prodhan, Parthak

AU - Bhutta, Adnan

AU - Jaquiss, Robert

AU - Imamura, Michiaki

AU - Fiser, Richard

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Extracorporeal membrane oxygenation (ECMO) is a lifesaving therapy, which has been used for the support of children with a broad range of diseases. Two pumps of differing mechanisms have been used to generate the extracorporeal flow: roller-head pumps and centrifugal pumps. Seven patients supported during ECMO with Levitronix Centrimag (Centrimag group [CG]) were matched to 14 patients supported with Stockert-Shiley SIII (Stockert-Shiley group [SSG]) at a single institution from July 2007 to July 2009. We hypothesized that hemolysis as measured by plasma-free hemoglobin (PFH) is elevated in the SSG versus the CG during cardiac ECMO. Categorical data were analyzed using Fisher's exact test. Plasma-free hemoglobin differences between groups were analyzed using both Wilcoxon rank sum and beta regression. Overall, SSG patients had two times the odds of having a higher PFH than CG patients adjusting for repeated measures (odds ratio [OR] = 1.96, 95% confidence interval [CI]: [1.15-3.34], p < 0.014). Differences between circuit failure in the first 168 hours did not reach statistical significance (1/7 CG vs. 7/14 SSG; p = 0.174). In this population of cardiac patients requiring ECMO support, more hemolysis occurred in the SSG, a roller-head pump supported group, when compared with the CG, a centrifugal pump supported group. Differences in circuit life did not reach statistical significance. This pilot study contrasts with past studies, which have demonstrated more hemolysis occurring with centrifugal pumps when compared with roller-head pumps.

AB - Extracorporeal membrane oxygenation (ECMO) is a lifesaving therapy, which has been used for the support of children with a broad range of diseases. Two pumps of differing mechanisms have been used to generate the extracorporeal flow: roller-head pumps and centrifugal pumps. Seven patients supported during ECMO with Levitronix Centrimag (Centrimag group [CG]) were matched to 14 patients supported with Stockert-Shiley SIII (Stockert-Shiley group [SSG]) at a single institution from July 2007 to July 2009. We hypothesized that hemolysis as measured by plasma-free hemoglobin (PFH) is elevated in the SSG versus the CG during cardiac ECMO. Categorical data were analyzed using Fisher's exact test. Plasma-free hemoglobin differences between groups were analyzed using both Wilcoxon rank sum and beta regression. Overall, SSG patients had two times the odds of having a higher PFH than CG patients adjusting for repeated measures (odds ratio [OR] = 1.96, 95% confidence interval [CI]: [1.15-3.34], p < 0.014). Differences between circuit failure in the first 168 hours did not reach statistical significance (1/7 CG vs. 7/14 SSG; p = 0.174). In this population of cardiac patients requiring ECMO support, more hemolysis occurred in the SSG, a roller-head pump supported group, when compared with the CG, a centrifugal pump supported group. Differences in circuit life did not reach statistical significance. This pilot study contrasts with past studies, which have demonstrated more hemolysis occurring with centrifugal pumps when compared with roller-head pumps.

UR - http://www.scopus.com/inward/record.url?scp=80052456671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052456671&partnerID=8YFLogxK

U2 - 10.1097/MAT.0b013e31822e2475

DO - 10.1097/MAT.0b013e31822e2475

M3 - Article

C2 - 21822124

AN - SCOPUS:80052456671

VL - 57

SP - 456

EP - 461

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 5

ER -